{
  "pmcid": "10566884",
  "sha256": "9f796376e4d7e5b940c2865c487ae31e7e35053d97b72cacccd8b9d476b51981",
  "timestamp_utc": "2025-11-09T23:07:40.529922+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.021774193548389,
    "reading_ease": 21.34208436724566,
    "word_count": 248
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Splinting and Steroid Injection for Trigger Finger"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "randomised into three groups: splinting (n = 43), steroid injection (n = 40), and combination therapy (n = 37)"
      },
      "Participants": {
        "score": 2,
        "evidence": "120 adult patients with trigger finger were randomised; Eligibility criteria included adults without prior corticosteroid injection or concomitant hand conditions"
      },
      "Intervention": {
        "score": 2,
        "evidence": "splinting involved wearing a fixed metacarpophalangeal joint orthosis; Steroid injection consisted of 1 mL of 1% lidocaine and 1 mL of triamcinolone acetonide"
      },
      "Objective": {
        "score": 1,
        "evidence": "evaluated the effectiveness of splinting alone, steroid injection alone, and their combination in reducing pain and improving function"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Primary outcomes were VAS pain reduction and MHQ score improvement at 6, 12, and 52 weeks"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using computer-generated block randomisation with allocation concealment via sequentially numbered, opaque, sealed envelopes"
      },
      "Blinding": {
        "score": 2,
        "evidence": "Both the allocator and outcome assessor were blinded"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "120 adult patients with trigger finger were randomised into three groups: splinting (n = 43), steroid injection (n = 40), and combination therapy (n = 37)"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "in both intention-to-treat and per-protocol analyses"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "No clinically important differences in VAS pain scores or MHQ scores were observed among the groups at any timepoint"
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}